# Clinical Cases: Female Reproductive Anatomy and Physiology

## Case 1: Turner Syndrome

### Clinical Image
![Turner Syndrome](case_01_image.jpg)
*Source: [Wikipedia - Turner syndrome](https://en.wikipedia.org/wiki/Turner_syndrome) - CC BY-SA 3.0*

### Case Presentation
A 16-year-old female is referred to endocrinology for evaluation of primary amenorrhea. She has never had a menstrual period and has minimal breast development. She is of short stature (height 4'8", below the 3rd percentile) despite her parents being of average height. Physical examination reveals Tanner stage I breast development, sparse pubic hair, a low posterior hairline, a webbed neck, a broad chest with widely spaced nipples, and multiple pigmented nevi. No goiter is palpated. External genitalia appear normal but immature. Laboratory studies show FSH 85 mIU/mL (markedly elevated), LH 42 mIU/mL (elevated), and estradiol <20 pg/mL (low). Karyotype reveals 45,X. Pelvic ultrasound demonstrates a small, infantile uterus and bilateral streak gonads (fibrous tissue without follicles). Echocardiogram shows a bicuspid aortic valve without significant stenosis or regurgitation. The diagnosis is Turner syndrome with gonadal dysgenesis. Treatment is initiated with low-dose estrogen to induce pubertal development, with gradual dose escalation and eventual addition of progesterone for cyclic withdrawal bleeding. The patient is counseled about infertility and the option of donor egg IVF in the future.

### Key Learning Points
- Turner syndrome (45,X) is the most common sex chromosome abnormality in females, characterized by short stature, gonadal dysgenesis, and variable somatic features
- Streak gonads result from accelerated oocyte loss; without functional ovaries, puberty does not occur spontaneously
- Elevated FSH with low estradiol (hypergonadotropic hypogonadism) confirms ovarian failure
- Cardiovascular abnormalities (bicuspid aortic valve, coarctation of the aorta) require screening; renal anomalies are also common

---

## Case 2: Ectopic Pregnancy

### Clinical Image
![Ectopic Pregnancy](case_02_image.jpg)
*Source: [Wikipedia - Ectopic pregnancy](https://en.wikipedia.org/wiki/Ectopic_pregnancy) - CC BY-SA 4.0*

### Case Presentation
A 28-year-old woman presents to the emergency department with 5 days of vaginal spotting and right lower quadrant pain. Her last menstrual period was 7 weeks ago. She has a history of pelvic inflammatory disease treated 3 years ago and uses an intrauterine device for contraception (which was removed 6 months ago when she and her partner decided to conceive). Vital signs are stable. Physical examination reveals right adnexal tenderness without peritoneal signs. Urine pregnancy test is positive. Serum beta-hCG is 2,400 mIU/mL. Transvaginal ultrasound shows no intrauterine gestational sac, a thickened endometrium, and a 2.5 cm adnexal mass with a yolk sac adjacent to the right ovary (tubal ring sign). No free fluid is seen in the pelvis. The diagnosis is unruptured ectopic pregnancy in the right fallopian tube. Given her hemodynamic stability, moderate beta-hCG level, and desire for future fertility, she is offered methotrexate treatment. She receives methotrexate 50 mg/m2 intramuscularly. Serial beta-hCG monitoring shows appropriate decline, and the ectopic pregnancy resolves without surgery.

### Key Learning Points
- The fallopian tube ampulla is the most common site of ectopic pregnancy and the normal site of fertilization; tubal damage (from PID, prior ectopic, or surgery) is the major risk factor
- The discriminatory zone (beta-hCG level at which an intrauterine pregnancy should be visible on ultrasound, typically 1,500-2,000 mIU/mL) helps distinguish ectopic from early normal pregnancy
- Methotrexate is an option for hemodynamically stable patients with unruptured ectopic pregnancy and beta-hCG generally <5,000 mIU/mL
- Prior PID, particularly from Chlamydia, causes tubal damage that impairs oocyte transport and increases ectopic pregnancy risk

---

## Case 3: Pelvic Organ Prolapse

### Clinical Image
![Pelvic Organ Prolapse](case_03_image.jpg)
*Source: [Wikipedia - Pelvic organ prolapse](https://en.wikipedia.org/wiki/Pelvic_organ_prolapse) - CC BY-SA 4.0*

### Case Presentation
A 62-year-old G4P4 postmenopausal woman presents with a sensation of vaginal pressure and fullness that has progressively worsened over the past 2 years. She reports a "bulge" that she can feel protruding from the vagina, especially after prolonged standing. She also experiences urinary urgency and frequency, and incomplete bladder emptying requiring her to manually reduce the prolapse to urinate. She has had four vaginal deliveries, with her largest baby weighing 4.2 kg. She underwent menopause at age 52 and has not used hormone therapy. Physical examination with the patient straining reveals a stage III cystocele (bladder prolapse through the anterior vaginal wall extending beyond the hymen), a stage II uterine prolapse, and a stage I rectocele. Post-void residual is 150 mL. Given her symptomatic prolapse affecting quality of life and bladder function, she is offered surgical repair. She undergoes vaginal hysterectomy with anterior and posterior colporrhaphy and uterosacral ligament suspension. Post-operatively, her symptoms resolve and bladder emptying normalizes.

### Key Learning Points
- Pelvic organ prolapse results from weakening of the pelvic support structures (levator ani muscles, cardinal and uterosacral ligaments) due to childbirth trauma, aging, and estrogen deficiency
- Risk factors include vaginal delivery (especially of large babies), multiparity, chronic straining (constipation, chronic cough), obesity, and connective tissue disorders
- Prolapse can involve the anterior compartment (cystocele), apical compartment (uterine/vaginal vault prolapse), and posterior compartment (rectocele)
- Treatment options include pelvic floor physical therapy, pessary placement, and surgical repair depending on symptom severity and patient goals